A.R.T. Advisors, LLC - VASCULAR BIOGENICS LTD ownership

VASCULAR BIOGENICS LTD's ticker is VBLT and the CUSIP is M96883109. A total of 27 filers reported holding VASCULAR BIOGENICS LTD in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
A.R.T. Advisors, LLC ownership history of VASCULAR BIOGENICS LTD
ValueSharesWeighting
Q4 2018$19,000
-64.8%
19,778
-19.9%
0.00%
-50.0%
Q2 2018$54,000
-37.2%
24,682
-34.7%
0.00%
-33.3%
Q1 2018$86,000
+87.0%
37,782
+277.2%
0.00%
+50.0%
Q2 2016$46,000
+31.4%
10,017
-1.4%
0.00%0.0%
Q1 2016$35,000
-89.8%
10,160
-84.4%
0.00%
-87.5%
Q4 2015$342,000
+72.7%
65,160
+145.3%
0.02%
+128.6%
Q3 2015$198,000
+65.0%
26,560
+14.7%
0.01%
+75.0%
Q1 2015$120,00023,1480.00%
Other shareholders
VASCULAR BIOGENICS LTD shareholders Q4 2018
NameSharesValueWeighting ↓
Telemetry Investments, L.L.C. 152,764$365,0000.50%
Ikarian Capital, LLC 800,811$1,915,0000.16%
DAFNA Capital Management LLC 306,980$734,0000.15%
PVG ASSET MANAGEMENT CORP 12,155$29,050,0000.09%
Phoenix Holdings Ltd. 1,060,300$2,534,0000.05%
Virtu Financial LLC 39,618$95,0000.01%
BOOTHBAY FUND MANAGEMENT, LLC 89,689$214,0000.01%
HBK Sorce Advisory LLC 22,000$53,0000.00%
MORGAN STANLEY 693,420$1,658,0000.00%
Bank of New York Mellon Corp 25,000$60,0000.00%
View complete list of VASCULAR BIOGENICS LTD shareholders